Progenics Pharmaceuticals Inc(PGNX)
4.10
Change: -0.02 (▼ -0.54%)
As of Tue 12/20/2022 01:10 PM% Of Value
Growth
Value Per Share
:
:
:
-155.30
123.95
-3.2800 (as of 19/06/2020)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 4.60 | Dividend | 70 |
| Close Price | 4.10 | DivYield | 0 % |
| High | 4.79 | Growth | 19.3 M |
| Low | 3.94 | Growth% | 123.95 |
| P/e | -5.523 | Volume | 34.9 M |
| P/b | -0.51 | Market Capital | 346.6 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 50 Days Moving Average Percentage | 1.4487804878049 (as of 06/04/2021 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2014 | Year2 / 2016 | Year3 / 2017 | Year4 / 2018 | Current Year / 2019 |
| Revenue | 0.0 | 0.0 | 11.6 M | 15.6 M | 34.9 M |
| Cap Spending | 0.0 | 0.0 | -232,000.0 | -817,000.0 | -15.2 M |
| Operating Expenses | 0.0 | 0.0 | 67.4 M | 87.7 M | 97.0 M |
| Operating Cash Flow | 0.0 | 0.0 | -55.8 M | -72.1 M | -65.2 M |
| Free Cash Flow | 0.0 | 0.0 | -53.8 M | -47.5 M | -89.9 M |
| Free Cash Flow Per Share | -0.766 | -0.611 | -1.05 | ||
| Total liabilities | 0.0 | 0.0 | 49.6 M | 44.5 M | 54.6 M |
| Total cash | 0.0 | 0.0 | 90.6 M | 137.6 M | 42.0 M |
| ROE% | -0.71 | -0.797 | -1.06 | ||
| Outstanding Shares | 0.0 | 0.0 | 72.6 M | 84.5 M | 86.5 M |
| P/E | -11.851 | -5.523 | -3.979 | ||
| P/S | 51.68 | 23.92 | 7.797 | ||
| Revenue USD | 0.0 | 0.0 | 11.6 M | 15.6 M | 34.9 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|